Chapter 13 Vocab

Question 1

schedule I

Answer 1

high abuse potential; no recognized medical purpose

• heroin, marijuana, LSD

Question 2

schedule II

Answer 2

high abuse potential; legitimate medical purpose

• fentanyl, ritalin, cocaine

Question 3

schedule III

Answer 3

lower potential for abuse than schedule II drugs

• hydrocodone, acetaminophen with codeine, ketamine

Question 4

schedule IV

Answer 4

lower potential for abuse than schedule III drugs

• valium, ativan

Question 5

schedule V

Answer 5

lower potential for abuse than schedule IV drugs

• narcotic cough medications

Question 6

plant source meds

Answer 6

atropine, aspirin, digoxin, morphine

Question 7

animal source meds

Answer 7

heparin, antivenom, thyroid preparations, insulin

Question 8

microorganism source meds

Answer 8

streptokinase, antibiotics

Question 9

mineral source meds

Answer 9

iron, magnesium sulfate, lithium, phosphorous, calcium

Question 10

class I

Answer 10

strong evidence supporting the use of medication

Question 11

class IIa

Answer 11

moderate evidence supporting the use of medication

Question 12

class IIb

Answer 12

weak evidence supporting the use of medication

Question 13

class III

Answer 13

evidence does not support that there is a benefit and may be harmful consequences

Question 14

class intermediate

Answer 14

either research is beginning on a treatment or research is continuing on a treatment

• cannot recommend for or against

Question 15

pharmacodynamics

Answer 15

biochemical and physiological effects and mechanism of a medication in the body

Question 16

pharmacokinetics

Answer 16

activity of medications in the body over time

• absorption, distribution, and elimination

Question 17

biotransformation

Answer 17

one of 4 rxns can occur:

1. an inactive substance can become active
2. an active medication can be changed to another medication
3. an active medication can be completely or partially inactivated
4. a medication is transformed into a substance that is easier to eliminate from the body

Question 18

alpha (α)-1 receptors

Answer 18

vasoconstriction of arteries and veins

Question 19

alpha (α)-2 receptors

Answer 19

• insulin restriction
• glucagon secretion
• inhibition of norepinephrine release

Question 20

beta (β)-1 receptors

Answer 20

• increased HR (chronotropic)
• increased myocardial contractility (intotropic)
• increased myocardial conduction (dromotropic)
• renin secretion for urine retention

Question 21

beta (β)-2 receptors

Answer 21

• bronchiole relaxation
• insulin secretion
• uterine relaxation
• arterial dilation in key organs

Question 22

dopaminergic receptors

Answer 22

vasodilation of renal and mesenteric arteries

Question 23

nicotinic

Answer 23

present at the NMJ, allows Acetyl-CoA to stimulate muscle contraction

Question 24

muscarinic-2 receptors

Answer 24

• present in the heart and activated by Acetyl CoA to offset stimulation of the SNS
• decreases HR, contractility, and electrical conduction velocity

Question 25

opioid receptors

Answer 25

• present in the central and peripheral NS, bowels, and various tissues
• produces analgesia, euphoria, respiratory depression
• 3 types: mu, kappa, and delta